SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-369109
Filing Date
2021-12-29
Accepted
2021-12-29 16:00:59
Documents
3
Group Members
INNOVATION CREDIT FUND VIII-A, L.P.SVB INNOVATION CREDIT FUND VIII, L.P.SVB INNOVATION CREDIT PARTNERS VIII, LLCSVB INNOVATION CREDIT PARTNERS VIII-A, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d267405dsc13g.htm SC 13G 97868
2 EX-99.1 d267405dex991.htm EX-99.1 7938
3 EX-99.2 d267405dex992.htm EX-99.2 1826
  Complete submission text file 0001193125-21-369109.txt   109674
Mailing Address 3003 TASMAN DRIVE SANTA CLARA CA 95054
Business Address 3003 TASMAN DR SANTA CLARA CA 95054 4086547400
SVB FINANCIAL GROUP (Filed by) CIK: 0000719739 (see all company filings)

IRS No.: 911962278 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6022 State Commercial Banks

Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 211528814
SIC: 2835 In Vitro & In Vivo Diagnostic Substances